Covaxin gets emergency use approval for kids

Hyderabad-based pharma major Bharat Biotech's Covaxin got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India. The Subject Expert Committee on Covid-19 gave the approval for the emergency use in the children.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iPPV7V
via IFTTT